documents: FDA-2013-D-1446-0025
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-D-1446-0025 | FDA | FDA-2013-D-1446 | Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use Guidance for Industry and Food and Drug Administration Staff | Other | Guidance | 2020-09-29T04:00:00Z | 2020 | 9 | 2020-09-29T04:00:00Z | 2024-11-06T23:40:03Z | 1 | 0 | 090000648489b535 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref